TADALAFIL 20 MG TABLET

Tadalafil
$0.1607per EA
High Outlier

Strength

20 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097052603

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA210255

On Market Since

2/5/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price History

1W

0.0%

1M

+3.8%

3M

-6.4%

6M

-21.1%

1Y

-30.0%

3Y

-56.0%

5Y

-78.9%

All

-91.6%